Drug profile · INN
sevelamer carbonate
RENVELA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sevelamer carbonate (RENVELA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sevelamer carbonate
Brand RENVELA
Route ORAL
Formulation FOR SUSPENSION
ATC code V03AE02
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is sevelamer carbonate?
sevelamer carbonate (RENVELA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sevelamer carbonate?
RENVELA is a marketed brand name for sevelamer carbonate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sevelamer carbonate?
sevelamer carbonate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.